Alerts
Other content recommended for you
- SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies
- Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
- OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
- Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis
- The EuroMyositis registry: an international collaborative tool to facilitate myositis research
- Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
- DIAGNOSIS AND TREATMENT OF INFLAMMATORY MUSCLE DISEASES
- Evaluation and treatment of inflammatory myopathies
- Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
- A tough one to swallow